Related references
Note: Only part of the references are listed.Radionuclide Therapy With 177Lu-PSMA in a Case of Metastatic Adenoid Cystic Carcinoma of the Parotid
Duygu Has Simsek et al.
CLINICAL NUCLEAR MEDICINE (2019)
PSMA targeted radioligandtherapy in metastatic castration resistant prostate cancer after chemotherapy, abiraterone and/or enzalutamide. A retrospective analysis of overall survival
K. Rahbar et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors
Charalambos Kaittanis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Targeting PSMA by radioligands in non-prostate disease-current status and future perspectives
Philipp Backhaus et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Imaging of Nonprostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to Arms
Roberto A. Salas Fragomeni et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study
Michael S. Hofman et al.
LANCET ONCOLOGY (2018)
Physiologic distribution of PSMA-ligand in salivary glands and seromucous glands of the head and neck on PET/CT
Thomas J. W. Klein Nulent et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY (2018)
Differences in patterns of survival in metastatic adenoid cystic carcinoma of the head and neck
Stijn van Weert et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2017)
Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis
Thomas J. W. Klein Nulent et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm?
Salvatore Alfieri et al.
ORAL ONCOLOGY (2017)
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells in vitro and correlating with progression in vivo
Maria Elisa Perico et al.
ONCOTARGET (2016)
An epidemiological evaluation of salivary gland cancer in the Netherlands (1989-2010)
Mischa de Ridder et al.
CANCER EPIDEMIOLOGY (2015)
The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions
Ali Afshar-Oromieh et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Adenoid cystic carcinoma of the head and neck - An update
Andres Coca-Pelaz et al.
ORAL ONCOLOGY (2015)
Salivary gland carcinoma in Denmark 1990-2005: A national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA)
Kristine Bjorndal et al.
ORAL ONCOLOGY (2011)
Survival from salivary glands adenoid cystic carcinoma in European populations
Laura Ciccolallo et al.
ORAL ONCOLOGY (2009)
Prostate-specific membrane antigen expression is a potential prognostic marker in endometrial adenocarcinoma
Paulette Mhawech-Fauceglia et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Avoiding infinite estimates of time-dependent effects in small-sample survival studies
Georg Heinze et al.
STATISTICS IN MEDICINE (2008)
Share Paper
